Maryam Aalamian‐Mattheis

Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial

Claus Vogelmeier, Mina Gaga, Maryam Aalamian‐Mattheis et al. · Respiratory Research · 2017 · 54 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and Safety of Serelaxin when Added to Standard of Care in Patients with Acute Heart Failure: Results from a PROBE Study, RELAX-AHF-EU

Aldo P. Maggioni, José López‐Sendón, Olav Wendelboe Nielsen et al. · European Journal of Heart Failure · 2019 · 32 citations · Full text

Medicine, Cardiology, Internal Medicine +11

Treatment response in COPD: does FEV₁say it all? A<i>post hoc</i>analysis of the CRYSTAL study

Κonstantinos Κostikas, Timm Greulich, Alexander Mackay et al. · ERJ Open Research · 2019 · 24 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)

A. Clemens, José M. Marı́n, Kai Michael Beeh et al. · International Journal of COPD · 2016 · 18 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study

Timm Greulich, Κonstantinos Κostikas, Mina Gaga et al. · International Journal of COPD · 2018 · 18 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12